ClearSkin

Company Overview

Snapshot

Founded in May 2017 by Milana Shternberg and Veronika Loiferman, ClearSkin operates with 1-10 employees. The company has developed and launched MiBiome, a first-generation product focused on the dermal microbiome to treat various skin conditions.

Business overview

ClearSkin Medical specializes in developing innovative treatments for skin diseases, focusing on the dermal microbiome. The company's core product, MiBiome, is an all-natural formulation with a probiotic complex designed to soothe and rebalance the skin's ecosystem. ClearSkin targets the healthcare and life sciences markets, serving patients and pharmaceutical companies within the dermatology, pharmaceuticals, and biotechnology sectors.

Company Intelligence Q&A

What is ClearSkin's primary product?

ClearSkin's primary product is MiBiome, a first-generation treatment focused on the dermal microbiome to address conditions such as psoriasis, atopic dermatitis, eczema, urticaria, and itching.

When was ClearSkin founded and by whom?

ClearSkin was founded in May 2017 by Milana Shternberg and Veronika Loiferman.

What is the core technology behind ClearSkin's products?

ClearSkin's core technology leverages biologicals, specifically microorganisms, to develop treatments that rebalance the skin's ecosystem.

Which markets does ClearSkin target?

ClearSkin targets the healthcare and life sciences markets, with a focus on patients and pharmaceutical companies dealing with skin conditions.

What types of skin conditions does MiBiome aim to treat?

MiBiome is designed to treat a range of skin conditions including psoriasis, atopic dermatitis, eczema, urticaria, and general itching.